ArchPoint Investors’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.81M Sell
220,528
-1,000
-0.5% -$8.21K 0.53% 39
2025
Q1
$1.58M Hold
221,528
0.52% 38
2024
Q4
$1.71M Sell
221,528
-2,750
-1% -$21.3K 0.56% 35
2024
Q3
$2.35M Hold
224,278
0.79% 31
2024
Q2
$2.62M Hold
224,278
0.99% 30
2024
Q1
$4.73M Hold
224,278
1.97% 16
2023
Q4
$4.03M Hold
224,278
1.68% 12
2023
Q3
$3.69M Hold
224,278
1.41% 18
2023
Q2
$4.48M Hold
224,278
1.73% 14
2023
Q1
$4.24M Hold
224,278
1.85% 12
2022
Q4
$5.09M Sell
224,278
-28,350
-11% -$643K 2.41% 11
2022
Q3
$6.68M Sell
252,628
-553
-0.2% -$14.6K 2.73% 10
2022
Q2
$6.25M Sell
253,181
-50,174
-17% -$1.24M 2.48% 13
2022
Q1
$10.1M Hold
303,355
3.47% 6
2021
Q4
$9.92M Buy
303,355
+6,000
+2% +$196K 2.94% 8
2021
Q3
$12.5M Buy
297,355
+10,219
+4% +$428K 3.73% 4
2021
Q2
$11.2M Buy
287,136
+36,078
+14% +$1.4M 3.78% 4
2021
Q1
$8.56M Sell
251,058
-48,189
-16% -$1.64M 2.43% 5
2020
Q4
$13.6M Buy
299,247
+843
+0.3% +$38.2K 3.76% 4
2020
Q3
$8.21M Sell
298,404
-2,557
-0.8% -$70.4K 2.62% 7
2020
Q2
$11.1M Buy
300,961
+1,500
+0.5% +$55.2K 3.55% 5
2020
Q1
$9.7M Sell
299,461
-490
-0.2% -$15.9K 3.82% 4
2019
Q4
$12.3M Buy
299,951
+490
+0.2% +$20.1K 3.76% 5
2019
Q3
$10.7M Buy
299,461
+52,124
+21% +$1.86M 3.61% 5
2019
Q2
$12.7M Buy
247,337
+6,600
+3% +$339K 4.02% 5
2019
Q1
$13.8M Buy
240,737
+18,090
+8% +$1.04M 4.12% 5
2018
Q4
$9.34M Sell
222,647
-1,540
-0.7% -$64.6K 3.24% 5
2018
Q3
$16.9M Buy
224,187
+18,473
+9% +$1.39M 4.6% 5
2018
Q2
$14.8M Buy
205,714
+3,290
+2% +$236K 4.25% 5
2018
Q1
$6.04M Buy
202,424
+15,886
+9% +$474K 1.78% 10
2017
Q4
$6.2M Sell
186,538
-500
-0.3% -$16.6K 1.94% 11
2017
Q3
$6.16M Buy
187,038
+19,018
+11% +$627K 1.96% 10
2017
Q2
$3.32M Buy
168,020
+131,020
+354% +$2.59M 1.06% 24
2017
Q1
$714K Buy
+37,000
New +$714K 0.27% 42